State Street Corporation »

Crispr Therapeutics shares owned by State Street Corporation

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by State Street Corporation

Quarter filed Position value Share count Share price at filing
2023-09-30 $86M 1.9M 45.39
2023-06-30 $92M 1.6M 56.14
2023-03-31 $90M 2.0M 45.23
2022-12-31 $85M 2.1M 40.65
2022-09-30 $103M 1.6M 65.35
2022-06-30 $95M 1.6M 60.77
2022-03-31 $30M 478k 62.77
2021-12-31 $16M 208k 75.78
2021-09-30 $18M 163k 111.93
2021-06-30 $24M 151k 161.89
2021-03-31 $17M 142k 121.85
2020-12-31 $21M 135k 153.11
2020-09-30 $12M 141k 83.64
2020-06-30 $8.9M 121k 73.49
2020-03-31 $3.0M 71k 42.41
2019-12-31 $2.9M 48k 60.91
2019-03-31 $931k 26k 35.73
2018-12-31 $753k 26k 28.57
2018-09-30 $1.2M 28k 44.38
2018-06-30 $1.4M 24k 58.76